[Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
The Authors have done a clinical study on the efficacy of desmopressin (DDAVP) tablets in the treatment of central diabetes insipidus in 13 patients who were previously treated with intranasal DDAVP. A comparison has been made between peroral and intranasal forms of DDAVP measuring the urinary volume and osmolarity daily. The right dosage of DDAVP tablets was between 150 and 600 micrograms/die. The patients showed very good compliance during the 4 weeks of treatment with DDAVP.
Carraro
A
A
Cattedra di Endocrinologia, Università di Genova.
Fano
M
M
Porcella
E
E
Bernareggi
V
V
Giusti
M
M
D000281:Administration, Intranasal; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000188:drug therapy* / Q000652:urine; D004231:Diuresis / Q000187:drug effects; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009994:Osmolar Concentration; D010342:Patient Acceptance of Health Care
D003894:Deamino Arginine Vasopressin
Trattamento del diabete insipido centrale con DDAVP per via orale. Confronto con il trattamento per via endonasale.